While clinical features may overlap with those of anti-IgLON5 disease, the neurodegenerative features with prominent neuronal loss, axonal spheroids and pigment that are characteristic findings in Perry syndrome were absent in all cases with anti-IgLON5 disease so far. This evidence concerns the gene IGLON5 and Perry syndrome.